In the tumor immune microenvironment, Treg cells maintain the metabolic fitness and mitochondrial integrity of M2-like tumor-associated macrophages indirectly by repressing IFNγ production derived from CD8+ T cells, which is dependent on SREBP-1 and its mediated fatty acid synthesis (55). The gene discussed is SREBF1; the disease is neoplasm.